276 related articles for article (PubMed ID: 17471597)
1. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
Suh GH; Greenspan AJ; Choi SK
Int J Geriatr Psychiatry; 2007 May; 22(5):494-5. PubMed ID: 17471597
[No Abstract] [Full Text] [Related]
2. Assertion that risperidone is superior to haloperidol for treatment of behavioural and psychological symptoms of dementia.
Jackson GA
Int J Geriatr Psychiatry; 2007 Mar; 22(3):268. PubMed ID: 17311359
[No Abstract] [Full Text] [Related]
3. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
4. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
Kurz A; Delius-Stute H; Rettig K; Schwalen S
MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
[TBL] [Abstract][Full Text] [Related]
6. Re: Chan et al. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Int J Geriatr Psychiatry 16: 1156 - 1162.
Onalaja D; Jainer AK
Int J Geriatr Psychiatry; 2002 Nov; 17(11):1076-7; author reply 1077. PubMed ID: 12404659
[No Abstract] [Full Text] [Related]
7. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
Suh GH; Greenspan AJ; Choi SK
Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
9. Risperidone and dementia-related aggression: new indication. A last resort, no better than haloperidol.
Prescrire Int; 2009 Dec; 18(104):248. PubMed ID: 20025088
[TBL] [Abstract][Full Text] [Related]
10. Mortality in elderly dementia patients treated with risperidone.
Haupt M; Cruz-Jentoft A; Jeste D
J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
[TBL] [Abstract][Full Text] [Related]
11. The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities.
Ballard CG; Margallo-Lana ML
J Clin Psychiatry; 2004; 65 Suppl 11():23-8. PubMed ID: 15264968
[TBL] [Abstract][Full Text] [Related]
12. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
[TBL] [Abstract][Full Text] [Related]
13. [Efficasy and safety of the use of risperidone (rispoluxe) in demented patients with psychotic and behavioural disorders].
Bocharov AV; Kondakova VE; Tuleninov ES
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6):25-31. PubMed ID: 22983233
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric outpatients].
Kurz A; Delius-Stute H; Rettig K; Schwalen S
MMW Fortschr Med; 2003 Oct; 145(42):55. PubMed ID: 14655446
[No Abstract] [Full Text] [Related]
15. Control of aggression and agitation in patients with dementia: efficacy and safety of risperidone.
De Deyn PP; Katz IR
Int J Geriatr Psychiatry; 2000 Jul; 15 Suppl 1():S14-22. PubMed ID: 10767745
[No Abstract] [Full Text] [Related]
16. Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementias.
Grossman F; Okamoto A; Turkoz I; Gharabawi G
J Am Geriatr Soc; 2004 May; 52(5):852-3. PubMed ID: 15086685
[No Abstract] [Full Text] [Related]
17. Establishing a dose-response relationship for oral risperidone in relapsed schizophrenia.
Ezewuzie N; Taylor D
J Psychopharmacol; 2006 Jan; 20(1):86-90. PubMed ID: 16174679
[TBL] [Abstract][Full Text] [Related]
18. An importance of dose in antipsychotic combination therapy for schizophrenia.
Suzuki T
J Clin Psychopharmacol; 2011 Jun; 31(3):399; author reply 399-400. PubMed ID: 21532376
[No Abstract] [Full Text] [Related]
19. [Changeover to risperidone after treatment with conventional low potency neuroleptics in dementia patients. An observation study during usage].
Stoppe G; Schreiner A; Schmitt AB
Dtsch Med Wochenschr; 2006 Mar; 131(9):423-9. PubMed ID: 16493564
[TBL] [Abstract][Full Text] [Related]
20. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR
Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
